Progression of Fabry Cardiomyopathy Despite Enzyme Replacement Therapy

被引：14
|
作者：
Pieroni, Maurizio [1 ]
Camporeale, Antonia [1 ]
Della Bona, Roberta [1 ]
Sabini, Alessandra [1 ]
Cosmi, Deborah [1 ]
Magnolfi, Annalisa [1 ]
Bolognese, Leonardo [1 ]
机构：
[1] San Donato Hosp, Cardiovasc & Radiol Dept, I-52100 Arezzo, Italy
来源：
CIRCULATION | 2013年 / 128卷 / 15期
关键词：
D O I：
10.1161/CIRCULATIONAHA.113.002799
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1687 / 1688
页数：2
相关论文
共 50 条
  • [31] Enzyme replacement therapy in an adolescent with Fabry disease
    Sabine Illsinger
    Thomas Luecke
    Hendrik Langen
    Anibh M. Das
    European Journal of Pediatrics, 2003, 162 : 522 - 523
  • [32] Utility of enzyme replacement therapy in Fabry disease
    Manuel Politei, Juan
    Dubroysky, Alberto
    MEDICINA CLINICA, 2010, 134 (09): : 402 - 405
  • [33] Long term effects of enzyme replacement therapy on the fabry cardiomyopathy: the earlier the treatment the better the outcome
    Weidemann, F.
    Niemann, M.
    Breunig, F.
    Herrmann, S.
    Emmert, A.
    Beer, M.
    Voelker, W.
    Ertl, G.
    Wanner, C.
    Strotmann, J.
    EUROPEAN HEART JOURNAL, 2008, 29 : 150 - 150
  • [34] Fabry disease: Efficacy of enzyme replacement therapy
    Zampetti, A.
    Amerio, P. L.
    De Simone, C.
    Antuzzi, D.
    Ricci, R.
    Feliciani, C.
    ACTA PAEDIATRICA, 2007, 96 : 102 - 102
  • [35] Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in Fabry's cardiomyopathy
    Lui, Charles Y.
    Ju, Hyunsu
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (11): : 1557 - 1558
  • [36] Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in Fabry's cardiomyopathy
    Beer, Meinrad
    Weidemann, Frank
    Breunig, Frank
    Knoll, Anita
    Koeppe, Sabrina
    Machann, Wolfram
    Hahn, Dietbert
    Wanner, Christoph
    Strotmann, Jorg
    Sandstede, Jorn
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (10): : 1515 - 1518
  • [37] Amelioration of serum 8-OHdG level by enzyme replacement therapy in patients with Fabry cardiomyopathy
    Chen, Kuan-Hsuan
    Chou, Yueh-Ching
    Hsiao, Chen-Yuan
    Chien, Yueh
    Wang, Kang-Ling
    Lai, Ying-Hsiu
    Chang, Yuh-Lih
    Niu, Dau-Ming
    Yu, Wen-Chung
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 486 : 293 - 299
  • [38] Evaluating Enzyme Replacement Therapy in Fabry Disease
    Koskenvuo, Juha W.
    Kantola, Ilkka M.
    ARCHIVES OF INTERNAL MEDICINE, 2010, 170 (06) : 573 - 574
  • [39] Progression of Fabry cardiomyopathy
    Strotmann, Joerg
    Breunig, Frank
    Wanner, Christoph
    Weidemann, Frank
    CLINICAL THERAPEUTICS, 2007, 29 : S13 - S14
  • [40] Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy
    Schiffmann, Raphael
    Warnock, David G.
    Banikazemi, Maryam
    Bultas, Jan
    Linthorst, Gabor E.
    Packman, Seymour
    Sorensen, Sven Asger
    Wilcox, William R.
    Desnick, Robert J.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (07) : 2102 - 2111
12345